UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · IEX Real-Time Price · USD
15.14
-1.34 (-8.13%)
At close: Jul 2, 2024, 4:00 PM
15.17
+0.03 (0.20%)
After-hours: Jul 2, 2024, 7:16 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $622.71 million as of July 2, 2024. Its market cap has increased by 140.71% in one year.
Market Cap
622.71M
Enterprise Value
556.07M
1-Year Change
140.71%
Ranking
Category
Stock Price
$15.14
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $622.71M, an increase of 242.34%. That is a compound annual growth rate of 18.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 547.00M | 18.14% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Pennant Group | 703.07M |
| Embecta | 700.69M |
| Evolus | 693.72M |
| Phibro Animal Health | 690.18M |
| InnovAge Holding | 685.38M |
| PetIQ | 675.13M |
| AnaptysBio | 672.31M |
| OrthoPediatrics | 672.21M |